Download PDF
Thromb Haemost 1992; 67(01): 184
DOI: 10.1055/s-0038-1648406
Letters to the Editor
Schattauer GmbH Stuttgart

Prevention of Hepatitis C Virus Infestion in Children with Haemophilia A and B and von Willebrand’s Disease

W Kreuz
Zentrum der Kinderheilkunde, Abteilung für Päd. Häm. und Onk., Klinikum der J.-W.-Goethe-Universitiit, Frankfurt/M.
,
G Auerswald
*   Prof.-Hess-Kinderklinik, Bremen
,
C Brückmann
**   Universitätskinderklinik, Mtinchen
,
B Zieger
***   Universitätskinderklinik, Freiburg
,
R Linde
Zentrum der Kinderheilkunde, Abteilung für Päd. Häm. und Onk., Klinikum der J.-W.-Goethe-Universitiit, Frankfurt/M.
,
M Funk
Zentrum der Kinderheilkunde, Abteilung für Päd. Häm. und Onk., Klinikum der J.-W.-Goethe-Universitiit, Frankfurt/M.
,
K Auberger
**   Universitätskinderklinik, Mtinchen
,
A H Sutor
***   Universitätskinderklinik, Freiburg
,
R Rasshofer
****   Max-v.-Pettenkofer-Institut, München
,
M Roggendorf
****   Max-v.-Pettenkofer-Institut, München
› Author Affiliations
Further Information

Publication History

Received 08 October 1990

Accepted after revision 15 August 1991

Publication Date:
02 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Makris M, Preston FE, Triger DR. et al Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; i: 1117-1119
    PubMedGoogle Scholar
  • 2 Noel L, Guerois C, Maisonneuve P. et al Antibodies to hepatitis C virus in haemophilia. Lancet 1989; ii: 550
    PubMedGoogle Scholar
  • 3 Esteban JI, Esteban R, Viladomiu L. et al Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; ii: 294-297
    PubMedGoogle Scholar
  • 4 Roggendorf M, Deinhardt F, Rasshofer R. et al Antibodies to hepatitis C virus. Lancet 1989; ii: 324-325
    PubMedGoogle Scholar
  • 5 Heimburger N, Schwinn H, Gratz G. et al Faktor-VIII-Konzentrat, hochgereinigt und in Losung erhitzt. Drug Res 1981; 31: 619-622
    PubMedGoogle Scholar
  • 6 Hilfenhaus J, Herrmann A, Mauler R, Prince AM. Inactivation of the AIDS-causing retrovirus and other human viruses in antihemophilic plasma protein preparations by pasteurisation. Vox Sang 1986; 50: 208
    CrossrefPubMedGoogle Scholar
  • 7 Hilfenhaus J, Weidmann E. Pasteurization as an efficient method to inactivate blood borne viruses in factor VIII concentrates. Drug Res 1986; 36: 621
    PubMedGoogle Scholar
  • 8 Schimpf K, Mannucci PM, Kreuz W. et al Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. N Engl J Med 1987; 316: 918-922
    CrossrefPubMedGoogle Scholar
  • 9 Mannucci PM, Colombo M. Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. Thromb Haemostas 1989; 61: 532-534
    PubMedGoogle Scholar
  • 10 Colvin BT. Prevention of hepatitis C virus infection in haemophiliacs. Lancet 1990; i: 1474
    PubMedGoogle Scholar